Park Avenue Securities’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.39M | Buy |
+5,384
| New | +$1.39M | 0.01% | 648 |
|
2025
Q1 | – | Sell |
-4,431
| Closed | -$1.01M | – | 1453 |
|
2024
Q4 | $1.01M | Buy |
4,431
+2,228
| +101% | +$509K | 0.01% | 753 |
|
2024
Q3 | $538K | Sell |
2,203
-80
| -4% | -$19.5K | 0.01% | 945 |
|
2024
Q2 | $437K | Buy |
2,283
+17
| +0.8% | +$3.25K | 0.01% | 1023 |
|
2024
Q1 | $449K | Buy |
2,266
+382
| +20% | +$75.7K | 0.01% | 1011 |
|
2023
Q4 | $324K | Buy |
1,884
+208
| +12% | +$35.8K | ﹤0.01% | 1093 |
|
2023
Q3 | $248K | Buy |
+1,676
| New | +$248K | ﹤0.01% | 1137 |
|
2023
Q1 | – | Sell |
-3,128
| Closed | -$651K | – | 1067 |
|
2022
Q4 | $651K | Buy |
3,128
+67
| +2% | +$13.9K | 0.01% | 684 |
|
2022
Q3 | $668K | Sell |
3,061
-435
| -12% | -$94.9K | 0.01% | 617 |
|
2022
Q2 | $733K | Buy |
3,496
+300
| +9% | +$62.9K | 0.01% | 572 |
|
2022
Q1 | $775K | Buy |
3,196
+28
| +0.9% | +$6.79K | 0.01% | 573 |
|
2021
Q4 | $825K | Buy |
3,168
+82
| +3% | +$21.4K | 0.01% | 535 |
|
2021
Q3 | $813K | Sell |
3,086
-106
| -3% | -$27.9K | 0.02% | 497 |
|
2021
Q2 | $787K | Buy |
3,192
+20
| +0.6% | +$4.93K | 0.02% | 484 |
|
2021
Q1 | $615K | Buy |
3,172
+13
| +0.4% | +$2.52K | 0.01% | 517 |
|
2020
Q4 | $671K | Sell |
3,159
-261
| -8% | -$55.4K | 0.02% | 429 |
|
2020
Q3 | $586K | Sell |
3,420
-106
| -3% | -$18.2K | 0.02% | 397 |
|
2020
Q2 | $677K | Buy |
+3,526
| New | +$677K | 0.03% | 270 |
|
2020
Q1 | – | Sell |
-3,673
| Closed | -$569K | – | 535 |
|
2019
Q4 | $569K | Buy |
3,673
+492
| +15% | +$76.2K | 0.02% | 268 |
|
2019
Q3 | $430K | Buy |
+3,181
| New | +$430K | 0.02% | 278 |
|
2019
Q2 | – | Sell |
-2,862
| Closed | -$300K | – | 428 |
|
2019
Q1 | $300K | Buy |
+2,862
| New | +$300K | 0.02% | 307 |
|